Constipation nursing diagnosis plays a crucial role in the assessment and management of patients experiencing bowel elimination issues.
Frequently Asked Questions
What is the NANDA nursing diagnosis for constipation?
Constipation (00011) — defined as decrease in normal frequency of defecation accompanied by difficult or incomplete passage of stool and/or passage of excessively hard, dry stool. Related-to factors include insufficient fiber/fluid intake, inadequate physical activity, medications (opioids, iron, calcium-channel blockers), stress, and ignoring the urge to defecate. Perceived Constipation (00012) is the parallel diagnosis for laxative-overuse patients.
What key assessments guide constipation care planning?
Rome IV criteria for chronic constipation, Bristol Stool Chart for stool consistency, abdominal palpation for fecal impaction, review of medications (opioids, iron, TCAs), fluid and fiber intake diary, activity level, and any recent bowel-habit changes. Document last bowel movement date, frequency, and characteristics — the care plan hinges on this baseline.
Which laxative should be chosen for a ward patient?
Start with bulk-forming (psyllium/isabgol) if hydration is adequate and there's no impaction. For opioid-induced constipation, osmotic laxatives (PEG, lactulose) work best. Stimulant laxatives (senna, bisacodyl) are for short-term rescue only — avoid in bedridden patients due to cramping. Never give bulk-forming laxatives to dehydrated patients or those with suspected obstruction.
How do I document and evaluate constipation interventions?
Chart daily: bowel-movement frequency and Bristol type, fluid intake, fiber intake, mobility level, laxative administration and effect. Evaluation criteria: return to patient's normal bowel pattern within 3 days, soft-formed stool (Bristol 3–4), no straining, no impaction. Escalate to physician if 5+ days without effective stool passage despite protocol, or if abdominal distension worsens.
Questions About This Article
Have a question? Ask the author directly.
Have a question about this article?
Ask Zocvi Editorial directly. Your question may help others with similar concerns.







Comments (0)